Table 3. Comparison of our outcomes with previous results of augmented trabeculectomy and deep sclerectomy in uveitis.
Reference | Procedure | Mean follow up (months) | Eyes (n) | Main IOP outcome | Success at 1 year (% eyes) | Success at 5 years (% eyes) | Long-term hypotony (% eyes) |
---|---|---|---|---|---|---|---|
Noble et al6 | MMC trab | 52 | 21 | <30% pre-op | 90.0 | NA | 9.5 |
Kaburaki et al7 | MMC trab | 65 | 53 | <21 mm Hg | NA | 79.1 (Q) | 28.3 |
Prata et al34 | MMC trab | 10 | 24 | <21 mm Hg | 91.7 | NA | 8.3 |
Ceballos et al11 | MMC trab | 29 | 44 | <21 mm Hg | 78.0 | NA | 7.0 |
Towler et al35 | 5-FU trab | 43 | 50 | <21 mm Hg | 88.0 (Q) | 67.0 (Q) | 0 |
Chawla et al12 | 5-FU trab | 61 | 31 | <21 mm Hg | 90.0 (Q) | 76.5 (Q) | 0 |
Al Obeidan26 | DS only | 21 | 13 | ‘IOP control’ at last visit | 84.6 (U) 92.3 (Q) | NA | 7.7 |
Al Obeidan29 | DS MMC | 33 | 33 | <23 mm Hg | 72.7(U)a 93.9 (Q)a | NA | 3.0 |
<18 mm Hg | 69.7 (U) 81.8 (Q) | NA | |||||
Auer et al27 | DS only | 12 | 14 | <21 mm Hg | 45.4 (U) 91.0 (Q) | NA | 7.1 |
Anand et al28 | DS MMC | >46 | 26 | <21 mm Hg | 89.0 (U/Q)b | NA | NA |
This study | DS MMC | >68 | 43 | <22 mm Hg | 88.0 (U) 93.0 (Q) | 60.0 (U) 74.0 (Q) | 4.7 |
<19 mm Hg | 81.0 (U) 86.0 (Q) | 51.0 (U) 60.0 (Q) | 4.7 |
Abbreviations: MMC, mitomycin C; trab, trabeculectomy; 5-FU, 5-fluorouracil; DS, deep sclerectomy; IOP, intraocular pressure; Q, qualified success; UQ, unqualified success.
Outcome data reported at<3 years.
Outcome data reported at 3 years.